SEQanswers

Go Back   SEQanswers > Literature Watch



Similar Threads
Thread Thread Starter Forum Replies Last Post
RNA-Seq: Genome-wide characterization of transcriptional start sites in humans by int Newsbot! Literature Watch 0 03-05-2011 03:01 AM
ChIP-Seq: Genome-wide mapping of RNA Pol-II promoter usage in mouse tissues by ChIP-s Newsbot! Literature Watch 0 09-17-2010 03:30 AM
PubMed: Genome-wide DNA methylation profiling of chronic lymphocytic leukemia allows Newsbot! Literature Watch 0 05-21-2010 03:00 AM
PubMed: Genome-wide identification, classification, and expression analysis of the ar Newsbot! Literature Watch 0 04-29-2010 03:00 AM

Reply
 
Thread Tools
Old 02-17-2011, 11:51 AM   #1
bgottgens
Junior Member
 
Location: cambridge uk

Join Date: Feb 2010
Posts: 4
Default Genome-wide analysis of transcriptional reprogramming in mouse models of leukemia

The paper below may be of interest to this forum:

http://www.ncbi.nlm.nih.gov/pubmed/21297973

"Genome-wide analysis of transcriptional reprogramming in mouse models of acute myeloid leukaemia"

Acute leukaemias are commonly caused by mutations that corrupt the transcriptional circuitry of haematopoietic stem/progenitor cells. However, the mechanisms underlying large-scale transcriptional reprogramming remain largely unknown. Here we investigated transcriptional reprogramming at genome-scale in mouse retroviral transplant models of acute myeloid leukaemia (AML) using both gene-expression profiling and ChIP-sequencing. We identified several thousand candidate regulatory regions with altered levels of histone acetylation that were characterised by differential distribution of consensus motifs for key haematopoietic transcription factors including Gata2, Gfi1 and Sfpi1/Pu.1. In particular, downregulation of Gata2 expression was mirrored by abundant GATA motifs in regions of reduced histone acetylation suggesting an important role in leukaemogenic transcriptional reprogramming. Forced re-expression of Gata2 was not compatible with sustained growth of leukaemic cells thus suggesting a previously unrecognised role for Gata2 in downregulation during the development of AML. Additionally, large scale human AML datasets revealed significantly higher expression of GATA2 in CD34+ cells from healthy controls compared with AML blast cells. The integrated genome-scale analysis applied in this study represents a valuable and widely applicable approach to study the transcriptional control of both normal and aberrant haematopoiesis and to identify critical factors responsible for transcriptional reprogramming in human cancer.
bgottgens is offline   Reply With Quote
Reply

Thread Tools

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off




All times are GMT -8. The time now is 04:04 PM.


Powered by vBulletin® Version 3.8.9
Copyright ©2000 - 2021, vBulletin Solutions, Inc.
Single Sign On provided by vBSSO